Although the 5% albumin monotherapy group did not reach statistical significance, this may stem from the limited sample size ( n = 22), necessitating validation through multicenter randomized controlled trials.
← all excerpts
Impact of albumin infusion on 30-day mortality in ICU patients with acute-on-chronic liver failure: a retrospective cohort using MIMIC-IV database.
1
—
—